Cited by 655interferon and immune responsesRespiratory viral infections researchImmune Response and Inflammation

The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index; none of the 257 sources its claims cite is checked for support yet.

The Airway Epithelium: Soldier in the Fight against Respiratory Viruses

Open access
Vareille, Marjolaine, Kieninger, Elisabeth, Edwards, Michael R., Regamey, Nicolas·2011·Clinical Microbiology Reviews

Abstract

SUMMARY: The airway epithelium acts as a frontline defense against respiratory viruses, not only as a physical barrier and through the mucociliary apparatus but also through its immunological functions. It initiates multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses. The interaction between respiratory viruses and airway epithelial cells results in production of antiviral substances, including type I and III interferons, lactoferrin, β-defensins, and nitric oxide, and also in production of cytokines and chemokines, which recruit inflammatory cells and influence adaptive immunity. These defense mechanisms usually result in rapid virus clearance. However, respiratory viruses elaborate strategies to evade antiviral mechanisms and immune responses. They may disrupt epithelial integrity through cytotoxic effects, increasing paracellular permeability and damaging epithelial repair mechanisms. In addition, they can interfere with immune responses by blocking interferon pathways and by subverting protective inflammatory responses toward detrimental ones. Finally, by inducing overt mucus secretion and mucostasis and by paving the way for bacterial infections, they favor lung damage and further impair host antiviral mechanisms.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review argues that the airway epithelium is a central frontline defender against respiratory viruses through physical barrier, mucociliary clearance, and innate/adaptive immune functions, but that viruses subvert these defenses to cause epithelial damage, dysregulated inflammation, mucus obstruction, and secondary bacterial infection. It synthesizes mechanisms of epithelial protection and viral evasion and discusses therapeutic implications.

Key findings

  • The airway epithelium defends against respiratory viruses via cell-cell junctions, the mucociliary escalator, and immune recognition through TLRs and intracellular sensors such as RIG-I/MDA5; it produces antiviral substances including type I and III interferons, lactoferrin, β-defensins, and nitric oxide, plus cytokines/chemokines that recruit innate and adaptive immune cells.
  • Respiratory viruses evade these defenses by inhibiting IFN synthesis or downstream signaling (e.g., RSV NS2 targets RIG-I; RSV NS1/NS2 inhibit STAT2; influenza NS1 inhibits PKR), disrupting tight junctions and epithelial repair, shifting Th1 responses toward Th2, and inducing mucus hypersecretion and mucostasis.
  • Viral respiratory tract infections are the most common illnesses worldwide; rhinoviruses are the most frequent agents, and vRTIs are linked to exacerbations of asthma, cystic fibrosis, and COPD and to later recurrent wheeze/asthma risk. The paper reports that vRTIs lead to more than 400,000 hospitalizations per year among children in the United States.
  • Viruses promote secondary bacterial infection: during influenza pandemics, bacterial coinfections with *Streptococcus pneumoniae*, *Haemophilus influenzae*, and *Staphylococcus aureus* contributed importantly to mortality, and the majority of deaths during the 1918–1919 flu pandemic were due to bacterial pneumonia. Mechanisms include decreased clearance, increased paracellular permeability, and virus-induced bacterial adherence.

Methods

  • Design: narrative review.
  • Data or sample: published literature on airway epithelial defense and respiratory virus pathogenesis; no primary cohort, experimental sample, or statistical analysis is reported.
  • Main analysis: thematic synthesis of epithelial barrier, mucociliary, innate, and adaptive immune mechanisms, viral evasion strategies, and pathways promoting bacterial infection; includes summary tables of the “wounded soldier” model and studies on bacterial adherence to human respiratory epithelial cells during viral infection.

Limitations

  • The paper does not state limitations.
  • Evident from the text: as a narrative review, it does not describe a systematic search strategy, inclusion criteria, or quantitative synthesis, and it relies on heterogeneous in vitro, animal, and clinical studies.
  • Evident from the text: several mechanisms are explicitly described as unresolved or speculative, including whether NLRP3 directly senses viral RNA, the role of airway epithelial cell-induced inflammation in virus-specific disease severity, and whether high inflammatory mediator levels reflect dysregulated inflammation versus increased viral replication.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/cmr.00014-10

Cites

341 of 341 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 257 cited sources checked · 0 supported · 0 flagged

Show all 112 claims

  • It may state two separate claims as one. 62
  • Probably not a substantial claim. 20
77 of 77
  • The paper relies on this without support.

    The airway epithelium is the main site of viral infection.

    “However, considering that the airway epithelium is the main site of viral infection, it is likely to contribute significantly to the type and magnitude of the inflammatory response.”
  • The paper relies on this without support.

    The physiochemical characteristics of the upper (nasal) and lower (bronchial) epithelia are very similar.

    “The general consensus is that the physiochemical characteristics of the upper (nasal) and lower (bronchial) epithelia are very similar”
  • The paper relies on this without support.

    The airway epithelium plays an important role as a protective physical and functional barrier between the external environment and underlying tissues and as a central element in the initiation and regulation of innate and adaptive immune responses in the lung.

    “The airway epithelium plays an important role as a protective physical and functional barrier between the external environment and underlying tissues and as a central element in the initiation and regulation of innate and adaptive immune responses in the lung.”
  • The paper relies on this without support.

    Airway epithelial cells are the principal hosts for respiratory viruses.

    “Airway epithelial cells are the principal hosts for respiratory viruses.”
  • The paper relies on this without support.

    Apoptosis acts as a protective mechanism to limit replication and spread of the virus to other cells, but exaggerated apoptosis can lead to a loss of integrity and protection of the epithelium, with detrimental consequences.

    “Apoptosis acts as a protective mechanism to limit replication and spread of the virus to other cells, but exaggerated apoptosis can lead to a loss of integrity and protection of the epithelium, with detrimental consequences.”
  • The paper relies on this without support.

    Epithelial repair initiates quickly after injury.

    “Epithelial repair initiates quickly after injury.”
  • The paper relies on this without support.

    Mucus contains many components that bind bacteria.

    “Mucus contains many components that bind bacteria.”
  • The paper relies on this without support.

    Most respiratory viral infections are self-limited and associated with minor morbidity.

    “Fortunately, most respiratory viral infections are self-limited and associated with minor morbidity.”
  • The paper relies on this without support.

    A frequent point of interference by viruses is the Jak-STAT signaling pathway, used by IFNs to induce transcription of antiviral genes.

    “A frequent point of interference by viruses is the Jak-STAT signaling pathway, used by IFNs to induce transcription of antiviral genes.”
9 of 9

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Bronchial cells are compared with bronchial cells instead of nasal cells

    Minor

    The text says bronchial epithelium produced higher viral loads than bronchial epithelial cells cultured the same way. The cited reference instead identifies the comparison as bronchial versus nasal cells.

  • Table 2 calls non-human specimens human

    Minor

    Table 2 is headed as a list of studies using human respiratory epithelial cells, but its first entry uses murine tracheal explants; other entries also list animal tissues or cells.

  • HPIV-3 is expanded as metapneumovirus rather than parainfluenza virus

    Minor

    Table 2's footnote expands HPIV-3 as human metapneumovirus type 3, whereas the paper's cited reference uses the name human parainfluenza virus type 3.

  • TLR7 is assigned two different RNA ligands

    Minor

    The first passage says TLR7 recognizes double-stranded RNA, while the later passage says TLR7 recognizes single-stranded RNA.

  • Table 2 misidentifies the bacterium in its 1982 study

    Minor

    The table lists S. pneumoniae for reference 131, but that reference's title identifies type 1a group B streptococci.

5 of 5

Citations

Cites

Items 201–341 of 341

Flagged first, then by citations

Research works printed but not linked: 1

  1. Yang, L., Y. Luo, J. Wei, and S. He. 2010. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3. Int. J. Mol. Med. 25 : 807-812.

Cited by

Sorted by citations

See all 655

Metadata

Authors
Vareille, M., Kieninger, E., Edwards, M. R., & Regamey, N.
Affiliations
  • Division of Respiratory Medicine, Department of Pediatrics, University Children's Hospital of Bern, Inselpital, 3010 Bern, Switzerland
  • University of Bern (CH)
  • Asthma UK (GB)
Venue
Clinical Microbiology Reviews
Published
2011-01
Volume
24
Issue
1
Pages
210-229
ISSN
  • 0893-8512 (ISSN-L)
  • 1098-6618
OpenAlex
W2145181045
Cited by
655
References
341
Citations by year
2026: 25 · 2025: 39 · 2024: 40 · 2023: 57 · 2022: 44 · 2021: 64 · 2020: 52 · 2019: 36 · 2018: 36 · 2017: 45 · 2016: 44 · 2015: 49 · 2014: 48 · 2013: 47 · 2012: 21
FWCI
3.55
Type
journal article
Language
en
Open access
Locations
  • Clinical Microbiology Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
Funders
National Institute for Health and Care Research (NF-SI-0508-10212)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
airway epithelium, respiratory viruses, innate immunity, interferon, lactoferrin, beta-defensins, nitric oxide, cytokines and chemokines, viral immune evasion, epithelial barrier integrity, mucus hypersecretion, mucostasis, lung injury, viral clearance
MeSH terms
Humans, Immunity, Innate, Respiratory Tract Infections, Viruses, Respiratory Mucosa, Adaptive Immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review